These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31484540)

  • 41. BCL6--regulated by AhR/ARNT and wild-type MEF2B--drives expression of germinal center markers MYBL1 and LMO2.
    Ding J; Dirks WG; Ehrentraut S; Geffers R; MacLeod RA; Nagel S; Pommerenke C; Romani J; Scherr M; Vaas LA; Zaborski M; Drexler HG; Quentmeier H
    Haematologica; 2015 Jun; 100(6):801-9. PubMed ID: 25769544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunoarchitectural patterns of germinal center antigens including LMO2 assist in the differential diagnosis of marginal zone lymphoma vs follicular lymphoma.
    Dyhdalo KS; Lanigan C; Tubbs RR; Cook JR
    Am J Clin Pathol; 2013 Aug; 140(2):149-54. PubMed ID: 23897248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnosis of Burkitt lymphoma using an algorithmic approach--applicable in both resource-poor and resource-rich countries.
    Naresh KN; Ibrahim HA; Lazzi S; Rince P; Onorati M; Ambrosio MR; Bilhou-Nabera C; Amen F; Reid A; Mawanda M; Calbi V; Ogwang M; Rogena E; Byakika B; Sayed S; Moshi E; Mwakigonja A; Raphael M; Magrath I; Leoncini L
    Br J Haematol; 2011 Sep; 154(6):770-6. PubMed ID: 21718280
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative immunohistochemical analysis of pediatric Burkitt lymphoma and diffuse large B-cell lymphoma.
    Frost M; Newell J; Lones MA; Tripp SR; Cairo MS; Perkins SL
    Am J Clin Pathol; 2004 Mar; 121(3):384-92. PubMed ID: 15023043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinicopathologic and immunohistochemical study of intra-abdominal non-Hodgkin B-cell lymphoma occurring in children].
    Yang WP; Zhu CD; Gong LP; Lü BB; Zou Y; Zhong HS; Xiao Q; Wu Y; Xu HY; Zeng ST; Huang H
    Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):759-64. PubMed ID: 20079016
    [TBL] [Abstract][Full Text] [Related]  

  • 46. De Novo Acute Myeloid Leukemia in Adults: Suppression of MicroRNA-223 is Independent of LMO2 Protein Expression BUT Associate With Adverse Cytogenetic Profile and Undifferentiated Blast Morphology.
    Akhter A; Patel JL; Farooq F; Qureshi A; Taher-Rad MS; Elyamany G; Al-Zahrani AM; Rashid-Kolvear F; Mansoor A
    Appl Immunohistochem Mol Morphol; 2015; 23(10):733-9. PubMed ID: 25710580
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of LMO2 protein expression on survival in chronic myeloid leukemia patients treated with imatinib mesylate.
    Sonmez M; Akagun T; Cobanoglu U; Topbas M; Erkut N; Yilmaz M; Ovali E; Omay SB
    Hematology; 2009 Aug; 14(4):220-3. PubMed ID: 19635185
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic Impact of MUM1/IRF4 Expression in Burkitt Lymphoma (BL): A Reappraisal of 88 BL Patients in Japan.
    Satou A; Asano N; Kato S; Elsayed AA; Nakamura N; Miyoshi H; Ohshima K; Nakamura S
    Am J Surg Pathol; 2017 Mar; 41(3):389-395. PubMed ID: 28079574
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic value of bcl-6, CD10 and CD38 immunoreactivity in stage I-II gastric lymphomas: identification of a subset of CD10+ large B-cell lymphomas with a favorable outcome.
    Ponzoni M; Ferreri AJ; Pruneri G; Pozzi B; Dell'Oro S; Pigni A; Pinotti G; Villa E; Freschi M; Viale G; Capella C
    Int J Cancer; 2003 Aug; 106(2):288-91. PubMed ID: 12800208
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.
    Dogan A; Bagdi E; Munson P; Isaacson PG
    Am J Surg Pathol; 2000 Jun; 24(6):846-52. PubMed ID: 10843287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LMO2 as a Biomarker for Hypersensitivity to Genotoxic Therapy.
    Scuoppo C; Zha S
    Cancer Cell; 2019 Sep; 36(3):211-212. PubMed ID: 31526755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High frequency of cryptic chromosomal rearrangements involving the LMO2 gene in T-cell acute lymphoblastic leukemia.
    Wu L; Xu Y; Wang Q; Ruan C; Drexler HG; Wu D; MacLeod RA; Chen S
    Haematologica; 2015 Jun; 100(6):e233-6. PubMed ID: 25682596
    [No Abstract]   [Full Text] [Related]  

  • 53. A phenotypic study of cells from Burkitt lymphoma and EBV-B-lymphoblastoid lines and their relationship to cells in normal lymphoid tissues.
    Ling NR; Hardie D; Lowe J; Johnson GD; Khan M; MacLennan IC
    Int J Cancer; 1989 Jan; 43(1):112-8. PubMed ID: 2536003
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overexpression of Lhx2 suppresses proliferation of human T cell acute lymphoblastic leukemia-derived cells, partly by reducing LMO2 protein levels.
    Miyashita K; Kitajima K; Goyama S; Kitamura T; Hara T
    Biochem Biophys Res Commun; 2018 Jan; 495(3):2310-2316. PubMed ID: 29278703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The A-myb gene is preferentially expressed in tonsillar CD38+, CD39-, and sIgM- B lymphocytes and in Burkitt's lymphoma cell lines.
    Golay J; Erba E; Bernasconi S; Peri G; Introna M
    J Immunol; 1994 Jul; 153(2):543-53. PubMed ID: 8021494
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sensitivity to dexamethasone and absence of bcl-2 protein in Burkitt's lymphoma cell line (Black93) derived from a patient with acute tumor lysis syndrome: comparative study with other BL and non-BL lines.
    Tani A; Tatsumi E; Nakamura F; Kumagai S; Kosaka Y; Sano K; Nakamura H; Amakawa R; Ohno H
    Leukemia; 1996 Oct; 10(10):1592-603. PubMed ID: 8847894
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LIM Domain Only 2 Regulates Endothelial Proliferation, Angiogenesis, and Tissue Regeneration.
    Meng S; Matrone G; Lv J; Chen K; Wong WT; Cooke JP
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies?
    Zaja F; Tabanelli V; Agostinelli C; Calleri A; Chiappella A; Varettoni M; Luigi Zinzani P; Volpetti S; Sabattini E; Fanin R; Pileri SA
    Am J Hematol; 2017 Jan; 92(1):E1-E2. PubMed ID: 27696517
    [No Abstract]   [Full Text] [Related]  

  • 59. Monoallelic or biallelic LMO2 expression in relation to the LMO2 rearrangement status in pediatric T-cell acute lymphoblastic leukemia.
    Van Vlierberghe P; Beverloo HB; Buijs-Gladdines J; van Wering ER; Horstmann M; Pieters R; Meijerink JP
    Leukemia; 2008 Jul; 22(7):1434-7. PubMed ID: 18079736
    [No Abstract]   [Full Text] [Related]  

  • 60. The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities.
    Gratzinger D; Zhao S; West R; Rouse RV; Vogel H; Gil EC; Levy R; Lossos IS; Natkunam Y
    Am J Clin Pathol; 2009 Feb; 131(2):264-78. PubMed ID: 19141387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.